AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Igor Bondarenko

Igor Bondarenko

Dnipro State Medical Academy - Dnipro / Ukraine
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1093918
Дніпровський державний медичний університет
person_outline Igor Bondarenko's MOST POPULAR ARTICLES
1-) Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer New England journal of medicine 378 (2), 113-125, 2018
2-) Ipilimumab plus dacarbazine for previously untreated metastatic melanoma New England Journal of Medicine 364 (26), 2517-2526, 2011
3-) Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma New England Journal of Medicine 380 (12), 1116-1127, 2019
4-) Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label … The Lancet 393 (10183), 1819-1830, 2019
5-) Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC New England Journal of Medicine 382 (1), 41-50, 2020